Alphamab combines antibody discovery platforms and GMP manufacturing expertise to its pipeline of nanobodies, bispecifics and multi-antibody cocktails.
Funding round amount (USD)
Funding round date
Results per page:
Page 1 of 1
Documentaries, videos and podcasts
November 16, 2020
TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced its corporate partners, Alphamab Oncology and 3D Medicines, have submitted a new drug applicatio